Optiver Holding
REGN icon

Optiver Holding’s Regeneron Pharmaceuticals REGN Stock Holding History

Optiver Holding’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-183
Closed -$141K – 2682
2025
Q4 		$141K Buy
+183
New +$124K ﹤0.01% 768
2025
Q2 		– Sell
-186
Closed -$118K – 1628
2025
Q1 		$118K Buy
+186
New +$128K ﹤0.01% 441
2024
Q2 		– Sell
-214
Closed -$206K – 1005
2024
Q1 		$206K Buy
+214
New +$203K 0.01% 474
2023
Q1 		– Sell
-3
Closed -$2K – 585
2022
Q4 		$2K Buy
+3
New +$2.21K ﹤0.01% 426
2022
Q1 		– Sell
-109
Closed -$66K – 822
2021
Q4 		$66K Hold
109
– – ﹤0.01% 368
2021
Q3 		$66K Buy
109
+84
+336% +$52.1K 0.01% 291
2021
Q2 		$14K Buy
+25
New +$12.7K ﹤0.01% 413

Other funds holding REGN

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return